1. ZHAW digitalcollection
  2. School of Management and Law
  3. Publikationen
  4. Publikationen School of Management and Law
Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-2788
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMattli, Renato-
dc.contributor.authorRiguzzi, Marco-
dc.contributor.authorGlinz, Dominik-
dc.contributor.authorRaatz, Heike-
dc.contributor.authorBucher, Heinz C.-
dc.contributor.authorWieser, Simon-
dc.date.accessioned2019-03-13T11:12:02Z-
dc.date.available2019-03-13T11:12:02Z-
dc.date.issued2018-06-
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/15996-
dc.description.abstractThe Swiss Federal Office of Public Health (SFOPH) commissioned a Health Technology Assessment (HTA) regarding iron therapy in symptomatic patients with iron deficiency without anemia (iron deficiency no anemia, IDNA) to the Basel Institute for Clinical Epidemiology and Biostatistics (CEB) and the Winterthur Institute of Health Economics (WIG). The scope, which describes the background of the HTA and elucidates the general approach, has been published on the SFOPH homepage. This HTA followed a step-wise approach. The aim of the first step was to assess the clinical effectiveness of iron therapy in symptomatic patients with IDNA, and to identify symptomatic populations that benefit from the therapy. In this first step, the clinical effectiveness of iron therapy was assessed in comparison to any other non-iron treatment or placebo, irrespective of the route of iron administration. This step was conducted by CEB, and the results are summarized in chapter 2 of this document. In the second step, which will be conducted by WIG, the economic evaluation shall compare parenteral versus oral iron therapy for those populations, for which a significant treatment effect of iron therapy (parenteral or oral) versus control could be identified during the first step. Based on the effectiveness results, the scope of the economic evaluation is outlined in chapter 4. Section 4.1 defines the objective of the economic evaluation. Section 4.2 defines the population, the intervention, the comparator, and the outcome (PICO) which will be evaluated. A screening of health economic literature and publicly available HTAs for economic studies comparing parenteral with oral iron therapy is presented in section 4.3, and section 4.4 concludes with the outline of the research methodology of the economic evaluation.de_CH
dc.format.extent22de_CH
dc.language.isoende_CH
dc.publisherBundesamt für Gesundheitde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subject.ddc362: Gesundheits- und Sozialdienstede_CH
dc.titleEconomic evaluation of oral versus parenteral iron therapy for iron deficiency without anemiade_CH
dc.typeWorking Paper – Gutachten – Studiede_CH
dcterms.typeTextde_CH
zhaw.departementSchool of Management and Lawde_CH
zhaw.organisationalunitWinterthurer Institut für Gesundheitsökonomie (WIG)de_CH
zhaw.publisher.placeBernde_CH
dc.identifier.doi10.21256/zhaw-2788-
zhaw.funding.euNode_CH
zhaw.originated.zhawYesde_CH
Appears in collections:Publikationen School of Management and Law

Files in This Item:
File Description SizeFormat 
Iron Therapy for Iron Deficiency without Anemia – Scope Economic Evaluation 2018 (nur auf Englisch).pdf289.92 kBAdobe PDFThumbnail
View/Open
Show simple item record
Mattli, R., Riguzzi, M., Glinz, D., Raatz, H., Bucher, H. C., & Wieser, S. (2018). Economic evaluation of oral versus parenteral iron therapy for iron deficiency without anemia. Bundesamt für Gesundheit. https://doi.org/10.21256/zhaw-2788
Mattli, R. et al. (2018) Economic evaluation of oral versus parenteral iron therapy for iron deficiency without anemia. Bern: Bundesamt für Gesundheit. Available at: https://doi.org/10.21256/zhaw-2788.
R. Mattli, M. Riguzzi, D. Glinz, H. Raatz, H. C. Bucher, and S. Wieser, “Economic evaluation of oral versus parenteral iron therapy for iron deficiency without anemia,” Bundesamt für Gesundheit, Bern, Jun. 2018. doi: 10.21256/zhaw-2788.
MATTLI, Renato, Marco RIGUZZI, Dominik GLINZ, Heike RAATZ, Heinz C. BUCHER und Simon WIESER, 2018. Economic evaluation of oral versus parenteral iron therapy for iron deficiency without anemia. Bern: Bundesamt für Gesundheit
Mattli, Renato, Marco Riguzzi, Dominik Glinz, Heike Raatz, Heinz C. Bucher, and Simon Wieser. 2018. “Economic Evaluation of Oral versus Parenteral Iron Therapy for Iron Deficiency without Anemia.” Bern: Bundesamt für Gesundheit. https://doi.org/10.21256/zhaw-2788.
Mattli, Renato, et al. Economic Evaluation of Oral versus Parenteral Iron Therapy for Iron Deficiency without Anemia. Bundesamt für Gesundheit, June 2018, https://doi.org/10.21256/zhaw-2788.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.